Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 95 shares at $85.00 ($8K) on 2019-08-19, disclosed to the SEC on 2019-08-21.
Scheduled sale ($8k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |